AHA Coding Clinic® for HCPCS - 2017 Issue 4; For Your Information
Pass-through status granted to eight drugs and biologicals effective January 1, 2018
HCPCS Code Long Description C9014 Injection, cerliponase alfa, 1 mg C9015 Injection, c-1 esterase inhibitor (human), haegarda, 10 units C9016 Injection, triptorelin extended release, 3.75 mg C9024 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine C9028 Injection, inotuzumab ozogamicin, 0.1 mg C9029 Injection, guselkumab, 1 mg J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg J9203 Injection, gemtuzumab ozogamicin, 0.1 mg ...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.
Thank you for choosing Find-A-Code, please Sign In to remove ads.